AAM
TMO icon

Ascension Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Ascension Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$3.96M Sell
7,159
-290
-4% -$166K 2.07% 10
2024
Q1 		$4.33M Buy
+7,449
New +$4.18M 2.33% 8
2023
Q2 		$3.95M Buy
+7,574
New +$4.09M 2.41% 7
2022
Q4 		$4.2M Sell
7,624
-70
-0.9% -$37.1K 3.03% 4
2022
Q3 		$3.9M Hold
7,694
– – 3.06% 4
2022
Q2 		$4.18M Buy
+7,694
New +$4.23M 3.08% 4
2021
Q4 		$6.76M Sell
10,138
-30
-0.3% -$18.7K 4.02% 3
2021
Q3 		$5.81M Sell
10,168
-50
-0.5% -$27.4K 3.8% 4
2021
Q2 		$5.16M Sell
10,218
-125
-1% -$59K 3.38% 4
2021
Q1 		$4.72M Buy
+10,343
New +$4.94M 3.31% 4
2020
Q4 		– Sell
-10,763
Closed -$4.75M – 93
2020
Q3 		$4.75M Buy
+10,763
New +$4.45M 3.8% 4
2020
Q1 		$3.09M Sell
10,888
-75
-0.7% -$23.6K 3.21% 4
2019
Q4 		$3.56M Sell
10,963
-25
-0.2% -$7.58K 3.07% 4
2019
Q3 		$3.2M Sell
10,988
-1,100
-9% -$315K 2.96% 4
2019
Q2 		$3.55M Hold
12,088
– – 3.13% 3
2019
Q1 		$3.31M Sell
12,088
-50
-0.4% -$12.4K 2.97% 4
2018
Q4 		$2.72M Sell
12,138
-200
-2% -$46.9K 2.76% 4
2018
Q3 		$3.01M Sell
12,338
-217
-2% -$49.9K 2.65% 7
2018
Q2 		$2.6M Sell
12,555
-2,430
-16% -$516K 2.38% 8
2018
Q1 		$3.09M Hold
14,985
– – 2.82% 4
2017
Q4 		$2.85M Buy
+14,985
New +$2.87M 2.59% 5

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ascension Asset Management's TMO Position: Q2 2024 in Review

Ascension Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 3.9% in Q2 2024, selling an estimated $166K and leaving 7,159 shares worth $3.96M. The position accounts for 2.07% of the portfolio, ranked #10.

Ascension Asset Management first reported a position in TMO in Q4 2017 and has held it in 21 quarters since. The position peaked at $6.76M in Q4 2021. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Ascension Asset Management held 7,159 shares of Thermo Fisher Scientific worth $3.96M as of Q2 2024.
  • Ascension Asset Management sold 290 Thermo Fisher Scientific shares in Q2 2024, an estimated $166K.
  • Thermo Fisher Scientific made up 2.07% of Ascension Asset Management's portfolio in Q2 2024, its #10 holding.
  • Ascension Asset Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 21 quarters since.
  • Ascension Asset Management's Thermo Fisher Scientific position peaked at $6.76M in Q4 2021.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Ascension Asset Management's 13F filing for Q2 2024, filed 16 Aug 2024.